These results support our hypothesis that obesity-induced inflammation is a significant contributor to metabolic dysregulation and that the anti-inflammatory activity of HE3286 can preferentially benefit the insulin-resistant inflamed subpopulation of obese IGT subjects. The gene discussed is INS; the disease is obesity disorder.